Stephen Toovey

Maternal immune activation and abnormal brain development across CNS disorders

Irene Knuesel, M. Britschgi, J. Hellings, 2014, Nature Reviews Neurology.

Development of a physiologically based pharmacokinetic model for mefloquine and its application alongside a clinical effectiveness model to select an optimal dose for prevention of malaria in young Caucasian children

Bruno Reigner, Neil Parrott, Trevor N Johnson, 2018, British journal of clinical pharmacology.

Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics

Nathorn Chaiyakunapruk, Huey Yi Chong, Richard E Nelson, 2017, British journal of clinical pharmacology.

Atovaquone-Proguanil versus Mefloquine for Malaria Prophylaxis in Nonimmune Travelers: Results from a Randomized, Double-Blind Study

Hans Dieter Nothdurft, David Overbosch, J. Knobloch, 2001 .

Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.

Jozef Vercruysse, Jean-Pierre Timmermans, J. Timmermans, 2008, Travel medicine and infectious disease.

Meeting Report: Risk Assessment of Tamiflu Use Under Pandemic Conditions

Jürg Oliver Straub, Mark Crane, Chris Watts, 2008, Environmental health perspectives.